Physician

Parth Patel, MD

According to 2025 Medicare claims, Parth Patel, MD (NPI: 1023547601) practices micrographic dermatologic surgery in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Somerset, NJ. This provider's primary affiliated billing organization is P AND S MEDICAL GROUP LLC (NPI: 1598480147; TIN: 881539023) and primary practice location at 08807-3064.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 641 traditional Medicare patients, billed 7,829 HCPCS/CPT codes, and received $739,774 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 805 prescription claims across 309 beneficiaries totaling $387,913 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 84 records totaling $1,656. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,628 and ending at $387,913. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$370K$740K2022 Medicare payment: $118,683 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $391,249 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $739,774 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022115329$118,683
20234141,721$391,249
20246417,829$739,774

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$194K$388K2017 Drug cost: $1,628 (USD; Tot_Drug_Cst)2018 Drug cost: $40,623 (USD; Tot_Drug_Cst)2019 Drug cost: $110,051 (USD; Tot_Drug_Cst)2020 Drug cost: $58,517 (USD; Tot_Drug_Cst)2021 Drug cost: $207,616 (USD; Tot_Drug_Cst)2022 Drug cost: $30,485 (USD; Tot_Drug_Cst)2023 Drug cost: $113,629 (USD; Tot_Drug_Cst)2024 Drug cost: $387,913 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R14$1,628
201869235$40,623
2019101377$110,051
2020104392$58,517
202177261$207,616
20222749$30,485
2023127335$113,629
2024309805$387,913

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks248325$541
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more310310$92
11102Biopsy of related skin growth, first growth157187$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more222357$79
17000Destruction of precancer skin growth, 1 growth138201$46

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab26714$103,165
OpzeluraRuxolitinib Phosphate13570$37,080
TacrolimusTacrolimus421,335$7,610
Clobetasol PropionateClobetasol Propionate792,492$3,520
CalcipotrieneCalcipotriene14580$2,812

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.84$1,656Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Parth Patel, MD?

Tedicare shows public-source Medicare data for Parth Patel, MD (NPI 1023547601), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Parth Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Parth Patel, MD?

Parth Patel, MD is linked to P AND S MEDICAL GROUP LLC (billing NPI 1598480147) in the available physician profile data.

Does Parth Patel, MD have Open Payments data?

Parth Patel, MD has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.